As an AI, I don't have personal opinions. However, I can provide an analysis. The point on the curve that one might advocate for in Comparative Effectiveness Research (CER) depends on several factors.

1. Cost-effectiveness: One might advocate for a point on the curve that represents the most cost-effective treatment. This is the point where the incremental cost-effectiveness ratio (ICER) is lowest.

2. Patient preferences: Another factor to consider is patient preferences and values. If a treatment is more effective but has side effects that patients find intolerable, they might prefer a less effective treatment with fewer side effects.

3. Societal values: In some cases, society might value certain outcomes more than others. For example, treatments that improve quality of life might be valued over those that merely extend life.

4. Budget impact: The overall impact on the healthcare budget is another factor to consider. Even if a treatment is cost-effective, if it is very expensive and used by many people, it could have a significant impact on the healthcare budget.

In conclusion, the point on the curve that one advocates for in CER depends on a balance of these factors.

Question

As an AI, I don't have personal opinions. However, I can provide an analysis. The point on the curve that one might advocate for in Comparative Effectiveness Research (CER) depends on several factors.

1. Cost-effectiveness: One might advocate for a point on the curve that represents the most cost-effective treatment. This is the point where the incremental cost-effectiveness ratio (ICER) is lowest.

2. Patient preferences: Another factor to consider is patient preferences and values. If a treatment is more effective but has side effects that patients find intolerable, they might prefer a less effective treatment with fewer side effects.

3. Societal values: In some cases, society might value certain outcomes more than others. For example, treatments that improve quality of life might be valued over those that merely extend life.

4. Budget impact: The overall impact on the healthcare budget is another factor to consider. Even if a treatment is cost-effective, if it is very expensive and used by many people, it could have a significant impact on the healthcare budget.

In conclusion, the point on the curve that one advocates for in CER depends on a balance of these factors.

Knowee AI · Accepted Answer

As an AI, I don't have personal opinions. However, I can provide an analysis. The point on the curve that one might advocate for in Comparative Effectiveness Research (CER) depends on several factors.

1. Cost-effectiveness: One might advocate for a point on the curve that represents the most cost-effective treatment. This is the point where the incremental cost-effectiveness ratio (ICER) is lowest.

2. Patient preferences: Another factor to consider is patient preferences and values. If a treatment is more effective but has side effects that patients find intolerable, they might prefer a less effective treatment with fewer side effects.

3. Societal values: In some cases, society might value certain outcomes more than others. For example, treatments that improve quality of life might be valued over those that merely extend life.

4. Budget impact: The overall impact on the healthcare budget is another factor to consider. Even if a treatment is cost-effective, if it is very expensive and used by many people, it could have a significant impact on the healthcare budget.

In conclusion, the point on the curve that one advocates for in CER depends on a balance of these factors.

The Pragmatist's Guide to Comparative Effectiveness Research Which point on the curve do you advocate for and why?

Question

The Pragmatist's Guide to Comparative Effectiveness Research

Solution

Similar Questions

Upgrade your grade with Knowee